Health
Multi-center Phase I study of anti-VISTA opens for patient enrollment – News-Medical.Net
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, no…
Reviewed by Emily Henderson, B.Sc.Oct 7 2020
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, now open and recruiting for patient enrollment. The trial is a Phase I study of CI-8993, an anti-VISTA (V-domain Ig Suppressor of T-cell Activation) antibody, in adult patients with advanced solid tumors.
VISTA is a checkpoint regulator whose function is to prevent activation of the immu…
-
Noosa News10 hours agoCrucial step in Sea World helicopter crash investigation set
-
Noosa News16 hours agoLocal input into new UN treaty – Proctor
-
Business10 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
Business15 hours agoIs the Qantas share price a buy in the tariff ASX stock market volatility?